Dr. F. Michael Walsh Is Named Chief Medical Officer of Aurora Diagnostics

PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Aurora
Diagnostics
, the leading independent specialized pathology company
focused on anatomic pathology and laboratory medicine integrating cancer
diagnostics for enhanced patient care, announced today that it has
promoted Dr. F. Michael Walsh to Chief Medical Officer.

“Dr. Walsh is an experienced physician leader, and we are excited by the
vision he brings to this important role,” said Daniel D. Crowley,
President, Chairman and CEO of Aurora Diagnostics. “He will lead
Aurora’s many physician-related initiatives, working closely with
Aurora’s Medical Advisory Committees, and help drive the development of
a robust personalized medicine program.”

Dr. Walsh will continue to serve as chair of Aurora’s Surgical Pathology
Medical Advisory Committee. He joined Aurora Diagnostics in October 2015
when Aurora acquired Laboratory Medicine of Greater Toledo, which he
founded.

“I am delighted to take on this new role,” said Dr. Walsh. “Aurora
Diagnostics is uniquely positioned to be the leader in the integration
of clinical diagnostics for enhanced patient care via its national group
of anatomic and clinical pathologists. As medicine rapidly advances with
amazing technologies, Aurora physicians are well positioned to translate
complex diagnostic information to optimize the effectiveness of
treatment plans. They have access to molecular and genetic testing
conducted under their direction in Aurora facilities. Their local
relationships and involvement in hospitals allow them to actively
participate as valued members of clinical care teams. And, the scope and
breadth of their collective training and experience creates an
unparalleled internal consultation network to increase the accuracy of
diagnoses. I know of no other organization that has Aurora’s unique and
expanding capabilities to integrate diagnostics and enhance patient
care.”

Dr. Walsh has served as the Chairman of the Department of Pathology and
Medical Director of the Clinical Laboratories for ProMedica Health
Systems for 27 years and integrated 12 hospital laboratories into that
health system. He is an active medical staff member at all ProMedica
Hospitals, an affiliate staff member of the Tomisch Institute of
Pathology and Laboratory Medicine of the Cleveland Clinic, and a
Clinical Associate Professor of Pathology at the University of Toledo
College of Medicine and Health Sciences (formerly the Medical College of
Ohio).

He earned his Bachelor of Science degree from the University of Notre
Dame and completed medical school at the Medical College of Wisconsin.
He also has a Master of Business Administration in Management from
Farleigh Dickinson University. Dr. Walsh’s training in pathology took
place at the National Naval Medical Center in Bethesda, Md., where he
was a Chief Resident of Anatomic and Clinical Pathology, and the
National Institutes of Health in Bethesda, Md. in chemical
pathology/clinical chemistry.

Dr. Walsh is certified by the American Board of Pathology in Anatomic,
Clinical and Chemical Pathology and the American Board of Medical
Management as a Certified Physician Executive.

About Aurora Diagnostics

Aurora Diagnostics is the leading independent specialized pathology
company focused on anatomic pathology and laboratory medicine
integrating cancer diagnostics for enhanced patient care.
The
company operates 26 freestanding lab locations and provides laboratory
medical directorship and professional services at 88 hospital locations
in the United States. Employing over 150 licensed physicians, Aurora
Diagnostics provides high-quality diagnostics and integrated testing
information for the patients of its primary referral
sources—dermatologists, OB/GYNs, gastroenterologists, urologists,
general surgeons, and oncologists. For additional information regarding
Aurora Diagnostics and the services it provides, please visit the
company website at 
www.auroradx.com.

Contacts

Media Relations:
Halldin Public Relations
Bill
Halldin,
916-781-0650
bill@HalldinPR.com